Metagen Therapeutics Completes Series A Financing Raising A Total Of 1.7 Billion Yen
Round Type
Series A
TsuruokaBiotechnologyHealth CareTherapeuticsInvestors
Description
Metagen Therapeutics (President & CEO: Taku Nakahara), a company focusing on drug discovery and development based on intestinal microbiome-based therapeutics for various diseases, has completed its Series A funding in 2 rounds, raising a total of 1.7 billion yen. Sparx Asset Management, Nippon Venture Capital, Mizuho Capital and SMBC Venture Capital have joined the 1st round investors of JIC Venture Growth Investments, a type of sovereign wealth fund in Japan, JAFCO, Japan's largest venture capital company, Fast Track Initiative and Keio Innovation Initiative.
Quick answer
Metagen Therapeutics raised an undisclosed amount in a Series A round, dated June 15, 2023. Investors: Nvcc, Sparx, Jic Vgi, Kii, Jafco, Fti, Keio Innovation Initiative and Fast Track Initiative. Metagen Therapeutics is based in Tsuruoka, Yamagata Prefecture, Japan.
- How much did Metagen Therapeutics raise?
- Metagen Therapeutics raised an undisclosed amount in a Series A round on June 15, 2023.
- Who invested in Metagen Therapeutics?
- Nvcc, Sparx, Jic Vgi, Kii, Jafco, Fti, Keio Innovation Initiative and Fast Track Initiative are named as investors in this round.
- What does Metagen Therapeutics do?
- Metagen Therapeutics, Inc. is a drug discovery and development company that leverages the power of gut microbiome design cultivated in Metabologenomics, Inc. We are eager for partnerships in pharmaceutical, healthcare,..
- Where is Metagen Therapeutics based and how big is it?
- Metagen Therapeutics is based in Tsuruoka, Yamagata Prefecture, Japan.
- Who are the decision-makers at Metagen Therapeutics?
- Fundz holds 1 contact at Metagen Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Metagen Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- KayoThera, Inc. raised an undisclosed amount (Series A) on July 19, 2023.
- SURGE Therapeutics raised $32M (Series B) on July 19, 2023.
- Renibus Therapeutics raised $47M (Funding Round) on July 18, 2023.
- Tenpoint Therapeutics raised $70M (Series A) on July 12, 2023.
- Smartlens raised $6.1M (Series A) on July 11, 2023.
- TolerogenixX raised $13M (Series A) on July 6, 2023.
Who to call at Metagen Therapeutics, and when
A new round usually means Metagen Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Metagen Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Metagen Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Metagen Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Metagen Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMetagen Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.